These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32629077)

  • 1. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis.
    Wang H; Li X; Peng R; Wang Y; Wang J
    Semin Cancer Biol; 2021 Jun; 71():21-32. PubMed ID: 32629077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic ablative radiotherapy for oligometastatic disease in liver.
    Kim M; Son SH; Won YK; Kay CS
    Biomed Res Int; 2014; 2014():340478. PubMed ID: 24868526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
    Comito T; Cozzi L; Clerici E; Campisi MC; Liardo RL; Navarria P; Ascolese A; Tozzi A; Iftode C; De Rose F; Villa E; Personeni N; Rimassa L; Santoro A; Fogliata A; Mancosu P; Tomatis S; Scorsetti M
    BMC Cancer; 2014 Aug; 14():619. PubMed ID: 25163798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
    Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for liver metastases.
    Aitken KL; Hawkins MA
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):307-15. PubMed ID: 25682933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado?
    Xing D; Siva S; Hanna GG
    Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):432-443. PubMed ID: 31005381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
    Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma.
    Lo CH; Huang WY; Lin KT; Lin MJ; Lin TP; Jen YM
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.
    Pennington JD; Park SJ; Abgaryan N; Banerjee R; Lee PP; Loh C; Lee E; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(4):537-42. PubMed ID: 25944395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life changes after stereotactic ablative radiotherapy for liver metastases: A prospective cohort analysis.
    Helou J; Thibault I; Chu W; Munoz-Schuffenegger P; Erler D; Rodrigues G; Warner A; Chan KKW; Chow E; Korol R; Davidson M; Chung HT
    Radiother Oncol; 2018 Dec; 129(3):435-440. PubMed ID: 30274721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy.
    Yoo GS; Rim CH; Cho WK; Jeong JU; Chie EK; Cho HM; Um JW; Ahn YC; Lee JH;
    Cancer Res Treat; 2023 Jul; 55(3):707-719. PubMed ID: 36960629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma.
    Cheung P; Thibault I; Bjarnason GA
    Curr Opin Support Palliat Care; 2014 Sep; 8(3):258-64. PubMed ID: 25090288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review.
    Kobiela J; Spychalski P; Marvaso G; Ciardo D; Dell'Acqua V; Kraja F; Błażyńska-Spychalska A; Łachiński AJ; Surgo A; Glynne-Jones R; Jereczek-Fossa BA
    Crit Rev Oncol Hematol; 2018 Sep; 129():91-101. PubMed ID: 30097241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.
    Connor MJ; Smith A; Miah S; Shah TT; Winkler M; Khoo V; Ahmed HU
    Eur Urol Oncol; 2020 Oct; 3(5):582-593. PubMed ID: 32891600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer.
    Mutsaers A; Greenspoon J; Walker-Dilks C; Swaminath A
    Radiat Oncol; 2017 Jun; 12(1):110. PubMed ID: 28662680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
    Palma DA; Olson R; Harrow S; Correa RJM; Schneiders F; Haasbeek CJA; Rodrigues GB; Lock M; Yaremko BP; Bauman GS; Ahmad B; Schellenberg D; Liu M; Gaede S; Laba J; Mulroy L; Senthi S; Louie AV; Swaminath A; Chalmers A; Warner A; Slotman BJ; de Gruijl TD; Allan A; Senan S
    BMC Cancer; 2019 Aug; 19(1):816. PubMed ID: 31426760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer.
    Sanuki N; Takeda A; Tsurugai Y; Eriguchi T
    Jpn J Radiol; 2022 Oct; 40(10):1009-1016. PubMed ID: 35857212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
    Walshaw RC; Honeychurch J; Illidge TM
    Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
    Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
    Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
    Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.